In this regard, it is noteworthy that elegant experiments by Román-Fernández and colleagues have shown PODXL to be a decoy receptor for galectin-3 which modifies its ability to alter integrin-dependent tumor cell invasion (12). Here, LGALS3 is linked to neoplasm.